Reference · Updated 11/4/2024
TFA content on a Certificate of Analysis
What residual trifluoroacetic acid (TFA) is, why it appears on peptide COAs, how it is measured, and what a TFA content figure does and does not tell you.
Trifluoroacetic acid (TFA) is a strong organic acid used throughout solid-phase peptide synthesis and reverse-phase HPLC purification. Because of that role, residual TFA can remain associated with a finished peptide as a counter-ion or trace solvent, and some Certificates of Analysis report a distinct TFA content figure alongside purity and identity data.
Where TFA comes from in synthesis
In standard Fmoc-based solid-phase peptide synthesis, TFA is the standard reagent used to cleave the finished peptide chain from its solid resin support and to remove acid-labile side-chain protecting groups. Downstream, reverse-phase HPLC purification typically uses a mobile phase containing a small percentage of TFA as an ion-pairing agent, because it improves peak shape and resolution for peptide separations.
Because a peptide chain carries basic side chains (lysine, arginine, histidine, and the free N-terminus), trifluoroacetate anions can associate with these positively charged sites, effectively becoming bound as a counter-ion in the final lyophilized solid rather than washing away entirely during purification.
How TFA content is measured
TFA content is typically quantified by ion chromatography (IC) or by ion-pair HPLC methods separate from the main identity/purity run, sometimes supplemented by nuclear magnetic resonance (NMR) or elemental/combustion analysis for fluorine content in more rigorous panels. The result is usually expressed as a mass percentage of the total lyophilized solid.
Why the figure matters analytically
TFA content is a component of what a lab calls 'net peptide content' — the fraction of a vial's total mass that is the peptide chain itself, once water content (by Karl Fischer titration) and counter-ion mass (TFA or otherwise) are subtracted from the gross lyophilized weight. A vial reporting 98% HPLC purity but a meaningful bound-TFA fraction will have a net peptide content noticeably lower than the raw purity percentage might suggest, because a portion of the total mass is non-peptide counter-ion rather than the peptide chain.
Some suppliers perform an additional ion-exchange step specifically to reduce residual TFA and report the resulting lower figure as a distinguishing specification on their COA.
Reading the number in context
A TFA content figure should always be read alongside — not instead of — the HPLC purity and mass-spec identity results. It answers a distinct analytical question: how much of the total lyophilized mass is a synthesis/purification byproduct rather than the target molecule. A COA that reports HPLC purity but omits any TFA or net-peptide-content figure has not addressed this question at all.